These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23892243)

  • 1. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.
    Conen A; Wang Q; Glass TR; Fux CA; Thurnheer MC; Orasch C; Calmy A; Bernasconi E; Vernazza P; Weber R; Bucher HC; Battegay M; Fehr J
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):472-8. PubMed ID: 23892243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
    Conen A; Fehr J; Glass TR; Furrer H; Weber R; Vernazza P; Hirschel B; Cavassini M; Bernasconi E; Bucher HC; Battegay M;
    Antivir Ther; 2009; 14(3):349-57. PubMed ID: 19474469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy.
    Kowalski S; Colantuoni E; Lau B; Keruly J; McCaul ME; Hutton HE; Moore RD; Chander G
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):455-61. PubMed ID: 22955054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    Tumwegamire A; Fatch R; Emenyonu NI; Lodi S; Muyindike WR; Kekibiina A; Adong J; Ngabirano C; Beesiga B; Marson K; Golabi N; Kamya M; Chamie G; Hahn JA
    PLoS One; 2024; 19(3):e0300508. PubMed ID: 38507431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.
    Pasternak AO; de Bruin M; Bakker M; Berkhout B; Prins JM
    PLoS One; 2015; 10(10):e0140791. PubMed ID: 26468956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.
    Shet A; Kumarasamy N; Poongulali S; Shastri S; Kumar DS; Rewari BB; Arumugam K; Antony J; De Costa A; D'Souza G
    Curr HIV Res; 2016; 14(1):71-9. PubMed ID: 26303008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
    Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
    AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
    Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
    HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia.
    McLaughlin A; Lin N; Jiang W; Lodi S; Lioznov D; Patts G; Gnatienko N; Blokhina E; Bendiks S; Freiberg MS; Tindle HA; Krupitsky E; Hahn JA; Samet JH; So-Armah K
    J Acquir Immune Defic Syndr; 2023 Nov; 94(3):244-252. PubMed ID: 37850982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India.
    Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V;
    BMJ; 2014 Oct; 349():g5978. PubMed ID: 25742320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.
    Kalichman SC; Grebler T; Amaral CM; McNerey M; White D; Kalichman MO; Cherry C; Eaton L
    J Gen Intern Med; 2013 Mar; 28(3):399-405. PubMed ID: 23065532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
    Glass TR; Sterne JA; Schneider MP; De Geest S; Nicca D; Furrer H; Günthard HF; Bernasconi E; Calmy A; Rickenbach M; Battegay M; Bucher HC;
    AIDS; 2015 Oct; 29(16):2195-200. PubMed ID: 26544582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.
    Hahn JA; Cheng DM; Emenyonu NI; Lloyd-Travaglini C; Fatch R; Shade SB; Ngabirano C; Adong J; Bryant K; Muyindike WR; Samet JH
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):492-501. PubMed ID: 29303844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the Association Between Alcohol and HIV Virologic Failure in a Military Cohort on Antiretroviral Therapy.
    Deiss RG; Mesner O; Agan BK; Ganesan A; Okulicz JF; Bavaro M; Lalani T; O'Bryan TA; Bebu I; Macalino GE
    Alcohol Clin Exp Res; 2016 Mar; 40(3):529-35. PubMed ID: 26916712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort.
    Ahonkhai AA; Adeola J; Banigbe B; Onwuatuelo I; Adegoke AB; Bassett IV; Losina E; Freedberg KA; Okonkwo P; Regan S
    J Int Assoc Provid AIDS Care; 2017; 16(1):98-104. PubMed ID: 28084189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    Long JE; Richardson BA; Wanje G; Wilson KS; Shafi J; Mandaliya K; Simoni JM; Kinuthia J; Jaoko W; McClelland RS
    PLoS One; 2020; 15(11):e0242817. PubMed ID: 33232378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.